Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells

Keyphrases

• Phosphorylation 100%
• Epidermal Growth Factor 100%
• Human Breast Cancer Cells 100%
• Forkhead Transcription Factors 100%
• Phosphoinositide 3-kinase (PI3K) 37%
• ErbB1 37%
• Immunoblot 25%
• Insulin 12%
• Growth Factors 12%
• Nuclear Proteins 12%
• Pharmacological Inhibitors 12%
• PI3K Inhibitor 12%
• Alkaline Phosphatase 12%
• Antiserum 12%
• Electrophoretic Mobility 12%
• Immunofluorescence Staining 12%
• Immunoblotting 12%
• LY294002 12%
• Retardation 12%
• Signaling Cascades 12%
• MDA-MB-231 12%
• Cytoplasmic Proteins 12%
• Consensus Site 12%
• MDA-MB-231 Cancer Cells 12%
• AG1478 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Transcription Factor FKHR 100%
• Epidermal Growth Factor 100%
• Western Blot 37%
• Phosphatidylinositol 3 Kinase 37%
• Epidermal Growth Factor Receptor 37%
• Growth Factor 12%
• 2 Morpholino 8 Phenylchromone 12%
• Phosphatidylinositol 3 Kinase Inhibitor 12%
• Cytoplasm Protein 12%
• 4 (3 Chloroanilino) 6,7 Dimethoxyquinazoline 12%
• Alkaline Phosphatase 12%
• Antiserum 12%
• Nuclear Protein 12%
• Forkhead Transcription Factor 12%

Neuroscience

• Epidermal Growth Factor 100%
• Transcription Factor FKHR 100%
• Phosphoinositide 3-Kinase 37%
• Epidermal Growth Factor Receptor 37%
• Immunoblotting 37%
• Staining Technique 12%
• Alkaline Phosphatase 12%
• LY294002 12%
• Cell Line 12%
• Cytoplasm Protein 12%
• Forkhead Transcription Factor 12%
• Growth Factor 12%
• Immunofluorescence 12%
• Antiserum 12%
• Nuclear Protein 12%
• Phosphoinositide 3-Kinase Inhibitor 12%